logo
logo
Sign in

Fetal Monitoring Market Is Projected To Reach 5.2 billion by 2026 | Growth & Key Business Strategies

avatar
Nilkanth Rathod
Fetal Monitoring Market Is Projected To Reach 5.2 billion by 2026 | Growth & Key Business Strategies

The fetal monitoring market is projected to reach USD 5.2 billion by 2026 from USD 3.7 billion in 2021, at a CAGR of 7.2% from 2021 to 2026. The development of noninvasive, portable, and advanced fetal monitors and emerging markets and strengthening infrastructure are expected to offer growth opportunities in the market during the forecast period.

The fetal monitoring market is expanding with the latest innovative technologies, backed by escalating research and product launches. Fetal monitoring technologies are now being streamlined to provide greater assistance in utero fetal surgeries, consisting of challenging physical fetal access and technological complications. Fetal cardiac assessments have also witnessed progress that supports high-fidelity hemodynamic and continuous physiologic monitoring, thus enabling early diagnosis and treatment.

Computer-Aided Decision Support Systems and Artificial Intelligence (AI) are also utilized in continuous cardiotocography (CTG) or fetal heart rate (FHR) auscultation during labor. The patient’s electronic health records (EHRs) are utilized along with computational methods, machine learning, and deep learning tools.

Research and technological advancements in fetal monitoring systems have increased focus on noninvasive monitoring procedures. Obstetrics has been introduced with noninvasive diagnosis technologies such as Doppler studies, cell-free fetal DNA assessment, electronic fetal monitoring (EFM), and fetal acid-base status. Fetal and neonatal assessments are carried out during antepartum via percutaneous umbilical cord blood sampling and during intrapartum with fetal scalp blood sampling immediately after birth. Fetal phonocardiography has been integrated with advanced data acquisition systems and databases. Progressing data analytics, synthetic data generation by advanced mathematical models, and classifications & processing algorithms are under active research & development to increase fetal motoring data processing efficacy.

 The probes used in the Doppler technology (for example, the Philips Doppler transducer) range from USD 4,500 to USD 17,000. The SonoScape system from GE Healthcare costs around USD 9,000. These machines also incur maintenance charges, which amount to 15% of the unit's purchasing cost. The high costs of fetal monitoring equipment can be challenging to low-income nations and low-resource hospitals, thus restraining this market's growth.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35700261

The key manufacturers in the market are expanding their product lines to include portable and wireless monitoring systems that are accurate, safe, and affordable. The key players in the market are also integrating telecommunication into these devices.

Ultrasound devices are the largest segment in this market. This segment's growth can primarily be attributed to technological advancements, increasing congenital anomalies, maternal mortality, and rising regulatory approvals.

Noninvasive methods are widely accepted for their safer method of diagnosing and monitoring the fetus, especially in high-risk pregnancies. The rising approvals of various noninvasive monitoring devices and the incoming advanced technologies drive the growth of this segment.

The antepartum segment accounts for the largest share of the fetal monitoring market. Antepartum fetal monitoring is carried out throughout the gestation period to diagnose any congenital fetal abnormalities.

The major players operating in this market are Cardinal Health, Inc. (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), Siemens Healthineers (Germany), FUJIFILM SonoSite, Inc. (US), Natus Medical Incorporated (US), Huntleigh Healthcare Limited (UK), The Cooper Companies Inc. (US), CONTEC Medical Systems Co., Ltd. (China), EDAN Diagnostics, Inc. (China), Neoventa Medical AB (Sweden), Bionet Co., Ltd. (South Korea)

collect
0
avatar
Nilkanth Rathod
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more